Skip to main content

Covid-Coag Controversies

From the 2021 Joint Annual Meeting (recorded 6/28/2021)
Presented by George Fritsma, MS, MLS(ASCP)

A hemostasis abnormality unmistakably associates with COVID progression, but what is the abnormality? Platelet activation? Arterial thrombosis? Sepsis? Hypofibrinolysis? How do we measure? D-dimer? TEG? PLT count? VWF? ADAMTS13? We apply routine and specialized hemostasis laboratory assay results to establish a model and to support COVID management.

At the conclusion of this presentation, participants will be able to:

  • Propose the pathophysiology and comorbidities associated with COVID.
  • Apply relevant COVID prognostic laboratory assays results
  • Align COVID lab results and pathophysiology with disease progress.

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General (Hematology) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Advanced-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.